Want to find out what’s been happening this year? Editor, Sharon Salt, highlights the best of 2018’s neuroscience and neurology research in an A–Z.
20 US states identified as ‘dementia neurology deserts’ in data presented at the 2017 Alzheimer’s Association International Conference
A scientific communication that attempts to understand the attitudes of Chinese medical students toward clinical neuroscience to provide a necessary step in curriculum development and reform in the neurosciences.
Editor, Lauren Pulling, introduces the newly renamed Neuro Central – bridging the gap between neuroscience and neurology.
In this report the authors explore the potential role of IGF2 methylation and the development of brain regions implicated in ADHD.
This article details a study exploring the attitudes toward analgesic therapy among persistent pain patients and health workers in palliative care in India.
An early precursor of the amyloid beta peptide, ßCTF, has been found to initiate a number of processes that can lead to the loss of neurons critical for memory formation in early Alzheimer’s disease.
A new method for classifying low and intermediate grade gliomas has recently been reported in the in the New England Journal of Medicine. This new approach could lead to improvements in diagnosis, treatment and potentially patient outcomes.
Arthur Roach, Research and Development Director at Parkinson’s UK, speaks to Neurology Central to discuss recent progress and current challenges involved in Parkinson’s research. In particular, we discuss the status of the anticipated glial cell-derived neurotrophic factor study.
This review discusses the future role of pharmacogenomics in the treatment of Alzheimer’s disease, and current opportunities.